{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:30:40Z","timestamp":1761532240540,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.brachy.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T22:50:30Z","timestamp":1660949430000},"page":"904-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individualized dosimetry in Ru-106 ophthalmic brachytherapy based on MRI-derived ocular anatomical parameters"],"prefix":"10.1016","volume":"21","author":[{"given":"Dimitrios A.","family":"Liakopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Perisinakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Solomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Kouvidakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni E.","family":"Drakonaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-9793","authenticated-orcid":false,"given":"Georgios","family":"Bontzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrosini","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios T.","family":"Detorakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2022.07.001_bib0001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0002","article-title":"American Brachytherapy Society - Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy."},{"key":"10.1016\/j.brachy.2022.07.001_bib0003","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1118\/1.596585","article-title":"Optimization of 125I ophthalmic plaque brachytherapy","volume":"17","author":"Astrahan","year":"1990","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0004","first-page":"191","article-title":"Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications","volume":"29","author":"Reichstein","year":"2018","journal-title":"CurrOpinOphthalmol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0005","first-page":"682","article-title":"Ein neuerWegzurkonservativen Therapy intraokularerTumorenmitBetastrahlen (Ruthenium 106) unterErhaltung der Sehf\u00e4higkeit [A new way in the conservative therapy of intraocular tumors by means of beta-irradiation (Ruthenium 106) with preservation of vision]","volume":"148","author":"Lommatzsch","year":"1966","journal-title":"KlinMonblAugenheilkd"},{"key":"10.1016\/j.brachy.2022.07.001_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000328254","article-title":"Ruthenium-106 brachytherapy","volume":"49","author":"Pe'er","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000479558","article-title":"Dose distributions and treatment margins in ocular brachytherapy with 106Ru eye plaques","volume":"4","author":"St\u00f6ckel","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brachy.2017.07.011","article-title":"MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy","volume":"17","author":"Zoberi","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmp.2020.07.019","article-title":"Personalized treatment planning in eye brachytherapy for ocular melanoma: dosimetric analysis on ophthalmic structure at risk","volume":"76","author":"Itta","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.brachy.2022.07.001_bib0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/eye.2017.205","article-title":"Clinical evaluation of a paper chart for predicting ruthenium plaque placement in relation to choroidal melanoma","volume":"32","author":"Rospond-Kubiak","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2022.07.001_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5114\/jcb.2013.34450","article-title":"The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options","volume":"5","author":"Astrahan","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0012","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1118\/1.597031","article-title":"Tumor localization using fundus view photography for episcleral plaque therapy","volume":"20","author":"Evans","year":"1993","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2017.01.024","article-title":"Local failure after episcleral brachytherapy for posterior uveal melanoma: patterns, risk factors, and management","volume":"177","author":"Bellerive","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2017.01.010","article-title":"Treatment plan optimization and robustness of 106Ru eye plaque brachytherapy using a novel software tool","volume":"123","author":"Heilemann","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.brachy.2017.06.014","article-title":"Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions","volume":"16","author":"Tien","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0016","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0360-3016(90)90077-W","article-title":"An interactive treatment planning system for ophthalmic plaque radiotherapy","volume":"18","author":"Astrahan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0017","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0360-3016(01)01768-0","article-title":"Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy","volume":"51","author":"Knutsen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0018","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0019","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1118\/1.1376441","article-title":"Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods","volume":"28","author":"Soares","year":"2001","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1118\/1.1573971","article-title":"A patch source model for treatment planning of ruthenium ophthalmic applicators","volume":"30","author":"Astrahan","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.001_bib0021","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1088\/1361-6560\/aa5696","article-title":"Monte Carlo simulation of ruthenium eye plaques with GEANT4: influence of multiple scattering algorithms, the spectrum and the geometry on depth dose profiles","volume":"62","author":"Sommer","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0022","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1111\/aos.14663","article-title":"3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas","volume":"99","author":"Espensen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0023","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21037\/cdt.2017.03.12","article-title":"Assessing observer variability: a user's guide","volume":"7","author":"Popovi\u0107","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.brachy.2022.07.001_bib0024","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5114\/jcb.2022.113271","article-title":"Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): visual atlas and literature review on response assessment","volume":"14","author":"Fionda","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","article-title":"(106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence","volume":"13","author":"Barker","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1196\/annals.1414.002","article-title":"Intra-operative echographic localization for radioactive ophthalmic plaques in choroidal melanoma","volume":"1138","author":"Al Mahmoud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.brachy.2022.07.001_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000381810","article-title":"A Modified Dummy Plaque for the Accurate Placement of Ruthenium-106 Plaques in Brachytherapy of Intraocular Tumours","volume":"2","author":"Krohn","year":"2015","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0028","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.brachy.2021.01.003","article-title":"MRI and dual-energy CT fusion anatomic imaging in Ru-106 ophthalmic brachytherapy","volume":"20","author":"Detorakis","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmp.2020.03.020","article-title":"Dual-energy CT imaging of orbits during episcleral brachytherapy with Ru-106 plaques: a phantom study on its potential for plaque position verification","volume":"73","author":"Perisinakis","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.brachy.2022.07.001_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.brachy.2015.04.010","article-title":"Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling","volume":"14","author":"Browne","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0031","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.brachy.2016.06.002","article-title":"Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques","volume":"15","author":"Johnson","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.001_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11030377","article-title":"MRI of uveal melanoma","volume":"11","author":"Ferreira","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2022.07.001_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1442-9071.2012.02809.x","article-title":"Ocular rigidity: biomechanical role, in vivo measurements and clinical significance","volume":"41","author":"Detorakis","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2022.07.001_bib0034","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow(\u22645\u2005mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:17:55Z","timestamp":1761531475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1538472122001143"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.07.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized dosimetry in Ru-106 ophthalmic brachytherapy based on MRI-derived ocular anatomical parameters","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}